Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids.


Journal

The FEBS journal
ISSN: 1742-4658
Titre abrégé: FEBS J
Pays: England
ID NLM: 101229646

Informations de publication

Date de publication:
01 2020
Historique:
received: 19 06 2019
accepted: 12 07 2019
pubmed: 16 7 2019
medline: 9 7 2020
entrez: 16 7 2019
Statut: ppublish

Résumé

Intestine is a major target of vitamin D and several studies indicate an association between vitamin D deficiency and inflammatory bowel diseases (IBD), but also increased colorectal cancer (CRC) risk and mortality. However, the putative effects of 1α,25-dihydroxyvitamin D

Identifiants

pubmed: 31306552
doi: 10.1111/febs.14998
pmc: PMC6972655
doi:

Substances chimiques

Calcium Channel Agonists 0
Receptors, Calcitriol 0
VDR protein, human 0
Calcitriol FXC9231JVH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-72

Informations de copyright

© 2019 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Références

Cell Stem Cell. 2017 Jun 1;20(6):801-816.e7
pubmed: 28285904
Mol Cell Endocrinol. 2017 Sep 15;453:79-87
pubmed: 27913273
Nat Rev Mol Cell Biol. 2017 Mar;18(3):159-174
pubmed: 28053348
Nutr Clin Pract. 2017 Jun;32(3):337-345
pubmed: 28537516
Gastroenterology. 2011 Nov;141(5):1762-72
pubmed: 21889923
Endocrinol Metab Clin North Am. 2017 Dec;46(4):815-843
pubmed: 29080638
Cell Stem Cell. 2008 Apr 10;2(4):333-44
pubmed: 18397753
Genome Biol. 2004;5(10):R80
pubmed: 15461798
Carcinogenesis. 2015 Jan;36(1):25-31
pubmed: 25344836
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Nat Med. 2011 Sep 04;17(10):1225-7
pubmed: 21892181
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Cell Biol. 2001 Jul 23;154(2):369-87
pubmed: 11470825
Oncogene. 2008 Jul 24;27(32):4467-77
pubmed: 18408752
Genome Med. 2017 Jul 18;9(1):66
pubmed: 28720124
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
PLoS One. 2014 May 02;9(5):e96695
pubmed: 24792400
Physiol Genomics. 2014 Apr 15;46(8):302-8
pubmed: 24550213
J Bone Miner Res. 1999 Feb;14(2):240-7
pubmed: 9933478
EMBO J. 2012 May 2;31(9):2064-6
pubmed: 22433838
J Cell Biochem. 2010 Jul 1;110(4):926-34
pubmed: 20564192
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Gut. 2012 Jun;61(6):847-54
pubmed: 22427238
Nat Rev Cancer. 2007 Sep;7(9):684-700
pubmed: 17721433
EMBO J. 2012 Jun 12;31(14):3079-91
pubmed: 22692129
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Hum Pathol. 2016 Apr;50:101-8
pubmed: 26997443
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
BMC Cancer. 2011 May 17;11:175
pubmed: 21575264
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Nature. 2007 Oct 25;449(7165):1003-7
pubmed: 17934449
J Steroid Biochem Mol Biol. 2019 Jan;185:1-6
pubmed: 29981368
J Physiol. 2019 May;597(10):2673-2690
pubmed: 30912855
Cell Rep. 2017 Jan 3;18(1):263-274
pubmed: 28052255
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2357-E2364
pubmed: 28270604
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):109-116
pubmed: 28259645
Epidemiol Rev. 2017 Jan 1;39(1):28-48
pubmed: 28486651
Gastroenterology. 2010 Feb;138(2):636-48, 648.e1-12
pubmed: 19818784
PLoS Comput Biol. 2015 Feb 23;11(2):e1004085
pubmed: 25706687
Mol Carcinog. 2012 May;51(5):411-21
pubmed: 21656576
J Steroid Biochem Mol Biol. 2016 Nov;164:246-253
pubmed: 26369615
Gut. 2017 Aug;66(8):1449-1462
pubmed: 27053631
BMC Bioinformatics. 2008 Sep 25;9:399
pubmed: 18817533
Cancer Res. 2011 Jan 15;71(2):413-23
pubmed: 21084270
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
N Engl J Med. 2012 Jan 5;366(1):44-53
pubmed: 22216841
Stem Cell Reports. 2015 Dec 8;5(6):979-987
pubmed: 26549850

Auteurs

Asunción Fernández-Barral (A)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Alba Costales-Carrera (A)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Sandra P Buira (SP)

Departments of Pathology and Surgery, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain.

Peter Jung (P)

Institute for Research in Biomedicine Barcelona (IRB), Barcelona, Spain.
DKTK, German Cancer Consortium, Research Group, Institute of Pathology, Ludwig-Maximilians University, Munich, Germany German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Gemma Ferrer-Mayorga (G)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

María Jesús Larriba (MJ)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Pilar Bustamante-Madrid (P)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Orlando Domínguez (O)

Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Francisco X Real (FX)

Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.
Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Laura Guerra-Pastrián (L)

Department of Pathology, La Paz University Hospital-IdiPAZ, Madrid, Spain.

Miguel Lafarga (M)

University of Cantabria-IDIVAL, Santander, Spain.

Damián García-Olmo (D)

Departments of Pathology and Surgery, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain.
Colorectal Unit, Department of Surgery, La Paz University Hospital-IdiPAZ, Madrid, Spain.

Ramón Cantero (R)

Colorectal Unit, Department of Surgery, La Paz University Hospital-IdiPAZ, Madrid, Spain.

Luis Del Peso (L)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Respiratory Diseases (CIBERES), Madrid, Spain.

Eduard Batlle (E)

Institute for Research in Biomedicine Barcelona (IRB), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Barcelona, Spain.
ICREA, Passeig Lluís Companys 23, 08010, Barcelona, Spain.

Federico Rojo (F)

Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.
Departments of Pathology and Surgery, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain.

Alberto Muñoz (A)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Antonio Barbáchano (A)

Departments of Cancer Biology and Biochemistry, Instituto de Investigaciones Biomédicas 'Alberto Sols', Spanish National Research Council (CSIC)-Autonomous University of Madrid (UAM) and IdiPAZ, Madrid, Spain.
Biomedical Research Networking Centres-Oncology (CIBERONC), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH